{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:27:05Z","timestamp":1790836025113,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>With improved prognosis for patients with Hodgkin's lymphoma (HL), interest increasingly focuses on high-risk groups such as elderly patients. We thus performed a retrospective analysis using the German Hodgkin's Study Group (GHSG) database to determine clinical risk factors, course of treatment, and outcome in elderly HL patients in comparison with younger adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>A total of 4,251 patients included in the GHSG studies HD5 to HD9 were analyzed, of whom 372 (8.8%) were 60 years or older and 3,879 (91.2%) were younger than 60 years. Patient characteristics, treatment results, toxicity, freedom from treatment failure (FFTF), and overall survival (OS) were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elderly patients more often had mixed cellularity subtype, \u201cB\u201d symptoms, elevated erythrocyte sedimentation rate, and poorer performance status. Less frequently observed were nodular sclerosis subtype, large mediastinal mass, and bulky disease. Acute toxicity during chemotherapy was generally higher in elderly patients. This was most obvious for severe infections (grade 3 or 4; 15% v 6%) correlating with more severe leukopenia in elderly patients (grade 4; 38% v 23%). As a result, significantly fewer elderly patients received the intended full chemotherapy dose (75% v 91%). The survival analysis showed a significantly poorer treatment outcome for elderly patients in terms of 5-year OS (65% v 90%), FFTF (60% v 80%), and HL-specific FFTF (73% v 82%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elderly patients have a poorer risk profile compared with younger HL patients and experience more severe treatment-associated toxicity. Higher mortality during treatment as well as lower dose-intensity are the major factors explaining the poorer overall outcome of elderly HL patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2005.11.080","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T23:44:08Z","timestamp":1118792648000},"page":"5052-5060","source":"Crossref","is-referenced-by-count":180,"title":["Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study Group"],"prefix":"10.1200","volume":"23","author":[{"given":"Andreas","family":"Engert","sequence":"first","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Ballova","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Haverkamp","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Pfistner","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Josting","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhart","family":"D\u00fchmke","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"M\u00fcller-Hermelink","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Diehl","sequence":"additional","affiliation":[{"name":"From the Department I of Internal Medicine, University of Cologne; German Hodgkin Study Group, University of Cologne, Cologne; Department of Radiation Oncology, Ludwig Maximilian Universit\u00e4t M\u00fcnchen, Munich; and Department of Pathology, University Hospital of W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272102"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1421"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1638"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.086"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2002.20.3.630"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022473"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.107"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-1-13"},{"key":"R9","unstructured":"Peterson BA, Pajak TF, Cooper MR, et al: Effect of age on therapeutic response and survival in advanced Hodgkin's disease. Cancer Treat Rep 66:889,1982-898,"},{"key":"R10","unstructured":"Bosi A, Ponticelli P, Casini C, et al: Clinical Data and therapeutic approach in elderly patients with Hodgkin's disease. Haematologica 74:463,1989-473,"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920815)70:4<830::AID-CNCR2820700418>3.0.CO;2-X"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a057939"},{"key":"R13","unstructured":"Levis A, Depaoli L, Urgesi A, et al: Probability of cure in elderly Hodgkin's disease patients. Haematologica 79:46,1994-54,"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2002.20.4.1087"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290033332"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)04596-0"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1159\/000224931"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840301)53:5<1202::AID-CNCR2820530530>3.0.CO;2-L"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930301)71:5<1857::AID-CNCR2820710524>3.0.CO;2-B"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050521"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900130104"},{"key":"R22","unstructured":"Levis A, Depaoli L, Bertini M, et al: Results of a low aggressivity chemotherapy regimen (CVP\/CEB) in elderly Hodgkin's disease patients. Haematologica 81:450,1996-456,"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Specht L, Nissen NI: Hodgkin's disease and age. Eur J Haematol 43:127,1989-135,","DOI":"10.1111\/j.1600-0609.1989.tb00268.x"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.6.947"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.023"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2275"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2002.20.2.476"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008294312741"},{"key":"R31","unstructured":"Landgren O, Algernon C, Axdorph U, et al: Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica 88:438,2003-444,"},{"key":"R32","unstructured":"Miller TP, LeBlanc M, Braziel RM, et al: Was the bimodal age incidence of Hodgkin's lymphoma a result of mistaken diagnoses of Non-Hodgkin's lymphoma? Blood 100:3048A,2002,"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900401)65:7<1635::AID-CNCR2820650730>3.0.CO;2-M"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi023"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.11.080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:12:28Z","timestamp":1653498748000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.11.080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["10.1200\/JCO.2005.11.080"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.11.080","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,1]]}}}